Daewoong Pharmaceutical Co Ltd 2022 Sustainability Report
Company: Daewoong Pharmaceutical Co Ltd
Sector: Manufacturing
Country: South Korea
Year: 2022
Type: Sustainability Report
Pages: 108
The report is Daewoong Pharmaceutical's first sustainability report, covering 2022 ESG performance and management activities. It presents a double materiality assessment that prioritizes thirteen issues and focuses on R&D and innovation, drug safety and quality, and talent and organizational culture. The report discloses environmental, social and governance performance data, including emissions, energy, water, waste, workforce and safety metrics, alongside SASB and GRI disclosures. An independent third-party assurance engagement by the Korean Standards Association covers specified economic, environmental and social information.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.